Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Daniel J. Wallace
ResearcherPublications, citations & collaboration network
Daniel J. Wallace is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 782 works, 42,859 citations, an h-index of 94 and an i10-index of 310.
782
Works
42,859
Citations
94
h-index
310
i10-index
How has Daniel J. Wallace's publication output changed over time?
ScholarIQpublication output · 1988–2019
Output grew100% over the shown period — from 1 works in 1988 to 2 in 2019.
1
1
2
2
1
2
1
2
19882003200520092011201220152019
What are the most-cited papers on Daniel J. Wallace?
ScholarIQmost cited works
Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus
Michelle Petri, Ana‐Maria Orbai, Graciela S. Alarcón, Caroline Gordon, Joan T. Merrill, Paul R. Fortin, Ian N Bruce, David Isenberg, Daniel J. Wallace, Ola Nived, Gunnar Sturfelt, Rosalind Ramsey‐Goldman, Sang‐Cheol Bae, John G. Hanly, Jorge Sánchez‐Guerrero, Ann E. Clarke, Cynthia Aranow, Susan Manzi, Murray Urowitz, Dafna D. Gladman, Kenneth Kalunian, Melissa Costner, Victoria P. Werth, Asad Zoma, Sasha Bernatsky, Guillermo Ruiz‐Irastorza, Munther A. Khamashta, Søren Jacobsen, Jill P. Buyon, Peter J. Maddison, Mary Anne Dooley, Ronald van Vollenhoven, Ellen M. Ginzler, Thomas Stoll, Christine Peschken, Joseph L. Jorizzo, Jeffrey P. Callen, S. Sam Lim, Barri J. Fessler, Murat İnanç, Diane L. Kamen, Anisur Rahman, Kristján Steinsson, Andrew G. Franks, Lisa Sigler, Suhail Hameed, Hong Fang, Ngoc Minh Pham, Robin L. Brey, Michael H. Weisman, Gerald McGwin, Laurence S. Magder
S132787887. 20125,341 CitationsOPEN ACCESS
2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus
Martin Aringer, Karen H. Costenbader, David Daikh, Ralph Brinks, Marta Mosca, Rosalind Ramsey‐Goldman, Josef S Smolen, David Wofsy, Dimitrios T. Boumpas, Diane L. Kamen, David Jayne, Ricard Cervera, N. Costedoat‐Chalumeau, Betty Diamond, Dafna D. Gladman, Bevra Hahn, Falk Hiepe, Søren Jacobsen, Dinesh Khanna, Kirsten Lerstrøm, Elena Massarotti, Joseph M. McCune, Guillermo Ruiz‐Irastorza, Jorge Sánchez‐Guerrero, Matthias Schneider, Murray B. Urowitz, George Βertsias, Bimba F. Hoyer, Nicolai Leuchten, Chiara Tani, Sara K. Tedeschi, Zahi Touma, Gabriela Schmajuk, Branimir Anić, Florence Assan, Tak Mao Chan, Ann E. Clarke, Mary K. Crow, László Czirják, Andrea Doria, W. Graninger, Bernadett Halda-Kiss, Sarfaraz Hasni, Peter Izmirly, Michelle Jung, Gabór Kumánovics, Xavier Mariette, Ivan Padjen, José María Pego‐Reigosa, Juanita Romero‐Díaz, Íñigo Rúa‐Figueroa Fernández, Raphaèle Séror, Georg Stummvoll, Yoshiya Tanaka, Maria G. Tektonidou, Carlos Vasconcelos, Edward M Vital, Daniel J. Wallace, Şule Yavuz, Pier Luigi Meroni, Marvin J. Fritzler, Ray Naden, Thomas Dörner, Sindhu R. Johnson
Arthritis & Rheumatology. 20192,584 CitationsOPEN ACCESS
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
Richard Furie, Michelle Petri, Omid Zamani, Ricard Cervera, Daniel J. Wallace, Dana Tegzová, Jorge Sánchez‐Guerrero, Andreas Schwarting, Joan T. Merrill, Winn Chatham, William Stohl, Ellen M. Ginzler, Douglas R. Hough, Z. John Zhong, William W. Freimuth, Ronald van Vollenhoven, BLISS-76 Study Group
S132787887. 20111,675 CitationsOPEN ACCESS
2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus
Martin Aringer, Karen H. Costenbader, David Daikh, Ralph Brinks, Marta Mosca, Rosalind Ramsey‐Goldman, Josef S Smolen, David Wofsy, Dimitrios T. Boumpas, Diane L. Kamen, David Jayne, Ricard Cervera, N. Costedoat‐Chalumeau, Betty Diamond, Dafna D. Gladman, Bevra Hahn, Falk Hiepe, Søren Jacobsen, Dinesh Khanna, Kirsten Lerstrøm, Elena Massarotti, Joseph M. McCune, Guillermo Ruiz‐Irastorza, Jorge Sánchez‐Guerrero, Matthias Schneider, Murray B. Urowitz, George Βertsias, Bimba F. Hoyer, Nicolai Leuchten, Chiara Tani, Sara K. Tedeschi, Zahi Touma, Gabriela Schmajuk, Branimir Anić, Florence Assan, Tak Mao Chan, Ann E. Clarke, Mary K. Crow, László Czirják, Andrea Doria, W. Graninger, Bernadett Halda-Kiss, Sarfaraz Hasni, Peter Izmirly, Michelle Jung, Gabór Kumánovics, Xavier Mariette, Ivan Padjen, José María Pego‐Reigosa, Juanita Romero‐Díaz, Íñigo Rúa‐Figueroa Fernández, Raphaèle Séror, Georg Stummvoll, Yoshiya Tanaka, Maria G. Tektonidou, Carlos Vasconcelos, Edward M Vital, Daniel J. Wallace, Şule Yavuz, Pier Luigi Meroni, Marvin J. Fritzler, Ray Naden, Thomas Dörner, Sindhu R. Johnson
Annals of the Rheumatic Diseases. 20191,553 CitationsOPEN ACCESS
American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis
Bevra H. Hahn, Maureen McMahon, Alan Wilkinson, William D. Wallace, David Daikh, John FitzGerald, George Karpouzas, Joan T. Merrill, Daniel J. Wallace, Jinoos Yazdany, Rosalind Ramsey‐Goldman, Karandeep Singh, Mazdak A. Khalighi, Soo‐In Choi, Maneesh Gogia, Suzanne Kafaja, Mohammad Kamgar, Christine Lau, W. J. Martin, Sefali Parikh, Justin Peng, Anjay Rastogi, Weiling Chen, Jennifer M. Grossman
Arthritis Care & Research. 20121,487 Citations
Related on ScholarIQ
Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus
Paper
2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus
Paper
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
Paper
2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus
Paper
American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis
Paper
Efficacy and safety of rituximab in moderately‐to‐severely active systemic lupus erythematosus: The randomized, double‐blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial
Paper